SEC Form 4 · accession 0001209191-17-015840
Alliqua BioMedical, Inc. · ALQA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
CELGENE CORP
10% Owner
Period of report
Feb 27, 2017
Accepted (ET)
Mar 1, 2017 · 4:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054274
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 27, 2017 | P | 4,000,000 | $0.50 | A | 7,046,100 | D |
Table II — derivative securities
No Table II lines on this filing.